A detailed history of Hrt Financial LP transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 11,955 shares of STOK stock, worth $135,330. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,955
Holding current value
$135,330
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$12.24 - $15.92 $146,329 - $190,323
11,955 New
11,955 $146,000
Q1 2023

May 12, 2023

SELL
$7.65 - $10.38 $297,141 - $403,179
-38,842 Reduced 35.87%
69,440 $578,000
Q4 2022

Feb 10, 2023

BUY
$7.07 - $15.69 $346,168 - $768,229
48,963 Added 82.54%
108,282 $999,000
Q3 2022

Nov 14, 2022

BUY
$12.56 - $22.53 $745,046 - $1.34 Million
59,319 New
59,319 $761,000
Q1 2022

May 16, 2022

SELL
$17.19 - $26.1 $310,399 - $471,287
-18,057 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$18.11 - $30.72 $327,012 - $554,711
18,057 New
18,057 $433,000

Others Institutions Holding STOK

About Stoke Therapeutics, Inc.


  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $446M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.